首页> 美国卫生研究院文献>Journal of the Endocrine Society >A Tale of Two Therapies- A Comparison of Armour Thyroid and Levothyroxine
【2h】

A Tale of Two Therapies- A Comparison of Armour Thyroid and Levothyroxine

机译:两种疗法的故事 - 甲状腺和左甲基的甲状腺和左旋甲胺的比较

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Treatment of hypothyroidism is predominantly with levothyroxine due to its ability to generate stable T3 levels and its long half-life. Many patients report continued hypothyroid symptoms despite normal TSH values on levothyroxine and request to switch to desiccated animal thyroid extract. Desiccated thyroid extract is less used for fear of side effects and risks. There are only a handful of studies available comparing desiccated animal thyroid extract to levothyroxine. We conducted a retrospective study on 250 hypothyroid patients over the age of 18 who presented to our clinic from 2008-2018. We excluded patients who had a history of thyroid cancer and documented non-adherence. We analyzed 125 patients on levothyroxine (males=43, females=82) and 125 patients who were on levothyroxine but chose to switch to Armour Thyroid (males=7, females=118). We examined the following variables; when comparisons of proportions were made between the two groups, N-1 chi square test was used to determine significance.
机译:由于其产生稳定的T3水平及其长半衰期,甲状腺功能亢进的治疗主要是左甲状腺素。许多患者报告仍在左旋呋喃的正常TSH值并要求切换到干燥的动物甲状腺提取物,仍然报告持续的甲状甲状腺症状。干燥的甲状腺提取物较少用于担心副作用和风险。只有一项可能的研究可用于将干燥的动物甲状腺提取物与左旋甲肾上腺素进行比较。我们对2008 - 2018年提交给我们诊所的18岁以上的250名甲状腺功能亢进患者进行了回顾性研究。我们排除了患者患有甲状腺癌的患者并记录了非依从性。我们分析了125名左旋呋喃(男性= 43,女性= 82)和125名左旋甲蛋白的患者,但选择切换到装甲甲状腺(Males = 7,女性= 118)。我们检查了以下变量;当两组之间进行比较比较的比较时,使用N-1 Chi正方形试验来确定显着性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号